Phoenixville, PA, United States of America

Mark T Winnett


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2004-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mark T Winnett: Innovator in Human Papilloma Virus Treatment

Introduction

Mark T Winnett is a notable inventor based in Phoenixville, PA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of human papilloma virus (HPV). With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

Winnett's latest patents focus on innovative methods for treating HPV infections. One of his key inventions involves a method of treating warts by administering a composition that includes a heat shock protein or an immunostimulatory fragment, along with a protein of a human papilloma virus or an antigenic fragment. Additionally, he has developed a method for treating HPV infections by using a similar composition, where the proteins involved are from different types of HPV. This dual approach highlights his innovative thinking in addressing viral infections.

Career Highlights

Throughout his career, Mark T Winnett has worked with several prominent companies in the biopharmaceutical sector. Notably, he has been associated with Nventa Biopharmaceuticals Corporation and Stressgen Biotechnologies Corporation. His experience in these organizations has contributed to his expertise in developing treatments for viral infections.

Collaborations

Winnett has collaborated with several professionals in his field, including John R Neefe and Stephen E Goldstone. These collaborations have likely enriched his research and development efforts, leading to his successful patent applications.

Conclusion

Mark T Winnett stands out as an innovative inventor in the realm of human papilloma virus treatment. His contributions through patented methods demonstrate his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…